4th Quarter - Report

CRANE STRATEGIES for SIGA TECHNOLOGIES

Period 4th Quarter 2016 Filed Jan 3, 2017 Signed by Steven E. Crane

Official filing
Firm
CRANE STRATEGIES
Client
SIGA TECHNOLOGIES
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Biodefense funding

LobbyistCovered position, as disclosed
STEVEN CRANE Subcommittee clerk, House Committee on Appropriations

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

S. 2055 Medical Countermeasure Innovation Act of 2016, issues relating to Priority Review Vouchers. H.R. 6 21st Century Cures Act, issues relating to Priority Review Vouchers. H.R. 3299 Strengthening Public Health Emergency Response Act of 2015, issues relating to Priority Review Vouchers.

LobbyistCovered position, as disclosed
STEVEN CRANE Staff assistant, US Senator Barbara Mikulski

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), H.R. 3299 (114th), S. 2055 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.